Dr Hugo Francon
In my endocrinology practice, I get one request on loop from patients who are better informed than ever and want to age gracefully: “How can I extend my lifespan and stay in good health?”
My role as a doctor is not just to treat but also to prevent the repercussions of chronic diseases while improving my patients’ quality of life on a day-to-day basis. This is where GLP-1 analogues (Glucagon-Like Peptide-1) come into play. Known for their spectacular weight-loss effect, these molecules, which I have prescribed for hundreds of patients for many years now, have proven to be outstanding modulators of biological aging. As well as slimming the figure, could they become the ultimate tool for boosting longevity?
A formidable tool for fighting metabolic aging
Aging is closely connected with the breakdown of our metabolism, which is often accelerated by three things: obesity, insulin resistance and systemic inflammation. By mimicking a natural intestinal hormone, GLP-1 receptor agonists attack the root of these dysfunctions.
Their first triumph is preventing diabetes. By stimulating the secretion of glucose-dependent insulin, they lead to a drastic reduction in pre-diabetes and a significant drop in glycated haemoglobin (HbA1c). This factor is crucial: stabilising the blood sugar blocks protein glycation – the “caramelisation” of our tissues, which accelerates cellular aging and leads to serious vascular complications.
More than weight loss: hidden anti-aging virtues
Though the media is flooded with stories of its weight-loss benefits, GLP-1 also offers benefits for longevity medicine. Cardiovascular disease, chronic kidney disease and diabetes can shorten a patient’s lifespan by up to 15 years. GLP-1 analogues act like a multisystemic shield:
• Cardiovascular and lipidic protection: They reduce atherogenic cholesterol and lower blood pressure, drastically reducing the risk of heart attack or stroke.
• Renal preservation: They slow down renal function deterioration, protecting the kidneys from age-related decline.
• Joint comfort: By reducing systemic inflammation, they have a beneficial effect on arthritis pain, allowing patients to recover their freedom of movement.
• Promising neurological benefits: Studies are currently in progress that suggest a promising neuroprotective effect, opening the gateway to a potential reduction in neurodegenerative disorders such as Alzheimer’s.
A lever for active longevity, but no miracle formula
Beware of the mirage: GLP-1 receptor agonists are not a miracle solution and should not be taken without careful consideration. To unleash their full potential for longevity, this powerful tool should never be taken on its own. In my practice, it is always part of a holistic treatment plan. It must go hand in hand with regular and suitable exercise (to maintain the muscle mass) and a well-structured diet, which is varied and rich in micronutrients.
When used wisely and under medical supervision, GLP-1 analogues can be a major turning point to optimise our patients’ life expectancy in good health and slim down the figure. My approach focuses on ethical and medically justified prescriptions. This tailored approach, which combines science and wellbeing, defines my vision of modern and active longevity.
Dr Hugo Francon
Specialist endocrinologist, diabetologist and nutritionist in Paris. Former clinic head for the Paris hospitals. Former house doctor in the Paris hospitals. Member of the ADELP and the FENAREDIAM.
Infos: francon@icpc.fr
